Sifted's mapping of 89 European biotech startups highlights a vibrant innovation pipeline poised to attract capital and reshape healthcare markets
Executive summary: Sifted published a mapping of 89 European biotech startups developing innovative therapies, diagnostics, and digital health solutions. It reveals a robust innovation pipeline that could attract significant investment and accelerate adoption of new medical technologies across Europe.
Who is involved: Sifted (media outlet), the featured European biotech startups, venture capital investors, and EU health policymakers.
Likely next: Continued tracking of funding rounds, potential follow‑on coverage by Sifted, and possible policy initiatives to support biotech growth.
Sifted’s article catalogues 89 European biotech companies working on novel therapies, diagnostics and digital health tools. The list underscores the depth of the region’s life‑science ecosystem and signals to investors where growth opportunities are concentrated. While the piece is descriptive, it implicitly points to increasing venture‑capital interest and the potential for these startups to influence treatment pathways and healthcare spending in Europe.
Timeline
- — Neko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’ (Sifted — EU startups)
- — European biotech mapped: 89 startups reshaping medicine (Sifted — EU startups)
- — BLOOD TEST MAY HELP PREDICT RISK OF COGNITIVE DECLINE DUE TO ALZHEIMER'S A DECADE BEFORE SYMPTOMS APPEAR (PR Newswire)
Analysis — what this means
Sectors affected
- European biotech
- medical diagnostics
- digital health
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped